1. Home
  2. ASRT vs WHWK Comparison

ASRT vs WHWK Comparison

Compare ASRT & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • WHWK
  • Stock Information
  • Founded
  • ASRT 1995
  • WHWK 2007
  • Country
  • ASRT United States
  • WHWK United States
  • Employees
  • ASRT N/A
  • WHWK N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • WHWK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASRT Health Care
  • WHWK Health Care
  • Exchange
  • ASRT Nasdaq
  • WHWK Nasdaq
  • Market Cap
  • ASRT 57.9M
  • WHWK 48.3M
  • IPO Year
  • ASRT 1997
  • WHWK N/A
  • Fundamental
  • Price
  • ASRT $0.65
  • WHWK $2.10
  • Analyst Decision
  • ASRT Strong Buy
  • WHWK
  • Analyst Count
  • ASRT 2
  • WHWK 0
  • Target Price
  • ASRT $3.25
  • WHWK N/A
  • AVG Volume (30 Days)
  • ASRT 207.4K
  • WHWK 154.5K
  • Earning Date
  • ASRT 08-06-2025
  • WHWK 08-15-2025
  • Dividend Yield
  • ASRT N/A
  • WHWK N/A
  • EPS Growth
  • ASRT N/A
  • WHWK N/A
  • EPS
  • ASRT N/A
  • WHWK 0.91
  • Revenue
  • ASRT $119,001,000.00
  • WHWK $27,775,000.00
  • Revenue This Year
  • ASRT N/A
  • WHWK $49.83
  • Revenue Next Year
  • ASRT $11.91
  • WHWK N/A
  • P/E Ratio
  • ASRT N/A
  • WHWK $2.29
  • Revenue Growth
  • ASRT N/A
  • WHWK 16.51
  • 52 Week Low
  • ASRT $0.51
  • WHWK $1.21
  • 52 Week High
  • ASRT $1.80
  • WHWK $3.81
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 49.30
  • WHWK N/A
  • Support Level
  • ASRT $0.60
  • WHWK N/A
  • Resistance Level
  • ASRT $0.68
  • WHWK N/A
  • Average True Range (ATR)
  • ASRT 0.03
  • WHWK 0.00
  • MACD
  • ASRT -0.00
  • WHWK 0.00
  • Stochastic Oscillator
  • ASRT 67.00
  • WHWK 0.00

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: